ClassID:

116461

C12Y301/21004 - CPC Classification

Classification description:

Hydrolases acting on ester bonds (3.1); Endodeoxyribonucleases producing 5'-phosphomonoesters (3.1.21) Type II site-specific deoxyribonuclease (3.1.21.4)

Recent Application in this class:
#1
20260151507
2026-06-04

COMPOSITIONS AND METHODS FOR GENOME EDITING

#2
20260146264
2026-05-28

METHODS FOR REPROGRAMMING AND GENE EDITING CELLS

#3
20260132437
2026-05-14

Methods of Synthesizing Nucleic Acid Molecules

#4
20260125712
2026-05-07

LYMPHOCYTE MEDIATED DELIVERY OF INTRACELLULAR TARGET-SPECIFIC PROTEINS

#5
20260125678
2026-05-07

DNA IMMORTALIZATION CONSTRUCT AND PERFORMING PRIMARY CELL IMMORTALIZATION

#6
20260078413
2026-03-19

METHODS AND PRODUCTS FOR EXPRESSING PROTEINS IN CELLS

#7
20260035679
2026-02-05

GENOME EDITING TECHNIQUE

#8
20250388934
2025-12-25

PROTEIN HAVING NUCLEASE ACTIVITY, FUSION PROTEINS AND USES THEREOF

#9
20250388913
2025-12-25

DNA ASSEMBLY

#10
20250382597
2025-12-18

Unconstrained Genome Targeting with near-PAMless Engineered CRISPR-Cas9 Variants

#11
20250361528
2025-11-27

NOVEL ZINC FINGER FUSION PROTEINS FOR NUCLEOBASE EDITING

#12
20250327048
2025-10-23

MODIFIED CASCADE RIBONUCLEOPROTEINS AND USES THEREOF

#13
20250230424
2025-07-17

MODIFIED CASCADE RIBONUCLEOPROTEINS AND USES THEREOF

#14
20250223578
2025-07-10

MODIFIED CASCADE RIBONUCLEOPROTEINS AND USES THEREOF

#15
20250034597
2025-01-30

RNA-Guided Targeting of Genetic and Epigenomic Regulatory Proteins to Specific Genomic Loci

#16
20240410023
2024-12-12

DETERMINING LINEAR AND CIRCULAR FORMS OF CIRCULATING NUCLEIC ACIDS

#17
20240352437
2024-10-24

High Fidelity Restriction Endonucleases

#18
20240318155
2024-09-26

NUCLEIC ACID-GUIDED NICKASES

#19
20240240207
2024-07-18

Increasing Specificity for RNA-Guided Genome Editing

#20
20240174998
2024-05-30

MODIFIED CASCADE RIBONUCLEOPROTEINS AND USES THEREOF

#21
20240093193
2024-03-21

DEAD GUIDES FOR CRISPR TRANSCRIPTION FACTORS

#22
20240043852
2024-02-08

DUAL STRAND NUCLEIC ACID-GUIDED NICKASE EDITING

#23
20230407341
2023-12-21

Using Truncated Guide RNAs (tru-gRNAs) to Increase Specificity for RNA-Guided Genome Editing

#24
20230374529
2023-11-23

RECONSTRUCTION OF SITE SPECIFIC NUCLEASE BINDING SITES

#25
20230040216
2023-02-09

RETROTRANSPOSONS AND USE THEREOF

#26
20220389470
2022-12-08

METHOD FOR IN VITRO TRANSCRIPTION USING AN IMMOBILIZED RESTRICTION ENZYME

#27
20220356493
2022-11-10

DNA-BINDING PROTEINS AND USES THEREOF

#28
20220275377
2022-09-01

Dual strand nucleic acid-guided nickase editing

#29
20220243228
2022-08-04

METHODS AND PRODUCTS FOR EXPRESSING PROTEINS IN CELLS

#30
20220213457
2022-07-07

Nucleic acid-guided nickases

#31
20220162583
2022-05-26

MITOCHONDRIAL GENOME EDITING METHODS

#32
20220145307
2022-05-12

Artificial nucleases comprising engineered cleavage half-domains

#33
20220090145
2022-03-24

RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci

#34
20220064229
2022-03-03

METHODS FOR DESIGNING DNA BINDING PROTEIN CONTAINING PPR MOTIFS, AND USE THEREOF

#35
20220025347
2022-01-27

Variants of CRISPR from Prevotella and Francisella 1 (Cpf1)

#36
20220017883
2022-01-20

Variants of CRISPR from Prevotella and Francisella 1 (Cpf1)

#37
20220010339
2022-01-13

PROTECTED GUIDE RNAS (PGRNAS)

#38
20220002757
2022-01-06

PROTEIN HAVING NUCLEASE ACTIVITY, FUSION PROTEINS AND USES THEREOF

#39
20210388396
2021-12-16

CRISPR-BASED GENOME MODIFICATION AND REGULATION

#40
20210324019
2021-10-21

DNA-BINDING PROTEIN USING PPR MOTIF, AND USE THEREOF

#41
20210284978
2021-09-16

Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants

#42
20210238566
2021-08-05

High fidelity restriction endonucleases

#43
20210207173
2021-07-08

CRISPR-BASED GENOME MODIFICATION AND REGULATION

#44
20210171926
2021-06-10

Modified cascade ribonucleoproteins and uses thereof

#45
20210130850
2021-05-06

Increasing specificity for RNA-guided genome editing

#46
20210079427
2021-03-18

CRISPR-BASED GENOME MODIFICATION AND REGULATION

#47
20200407799
2020-12-31

Determining linear and circular forms of circulating nucleic acids

#48
20200362369
2020-11-19

Protected guide RNAS (pgRNAS)

#49
20200354700
2020-11-12

CAS9-nucleic acid complexes and uses related thereto

#50
20200325496
2020-10-15

Methods and products for expressing proteins in cells

#51
20200325462
2020-10-15

Modified cascade ribonucleoproteins and uses thereof

#52
20200297762
2020-09-24

Methods and compositions for targeted cleavage and recombination

#53
20200248265
2020-08-06

ANALYSIS OF METHYLATION STATUS AND COPY NUMBER

#54
20200231988
2020-07-23

Artifical nucleases comprising engineered cleavage half-domains

#55
20200224222
2020-07-16

Using RNA-guided FokI nucleases (RFNs) to increase specificity for RNA-guided genome editing

#56
20200140897
2020-05-07

CRISPR-BASED GENOME MODIFICATION AND REGULATION

#57
20200102550
2020-04-02

TAL effector-mediated DNA modification

#58
20200071730
2020-03-05

Using truncated guide RNAs (tru-gRNAs) to increase specificity for RNA-guided genome editing

#59
20200056207
2020-02-20

Methods and products for expressing proteins in cells

#60
20200040365
2020-02-06

Methods and products for expressing proteins in cells

#61
20200040364
2020-02-06

Methods and products for expressing proteins in cells

#62
20200040363
2020-02-06

Methods and products for expressing proteins in cells

#63
20200040318
2020-02-06

Modified cascade ribonucleoproteins and uses thereof

#64
20200032299
2020-01-30

Methods and products for expressing proteins in cells

#65
20200032298
2020-01-30

Methods and products for expressing proteins in cells

#66
20200032297
2020-01-30

Methods and products for expressing proteins in cells

#67
20200032296
2020-01-30

Methods and products for expressing proteins in cells

#68
20200032295
2020-01-30

Methods and products for expressing proteins in cells

#69
20190376090
2019-12-12

RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci

#70
20190345519
2019-11-14

Methods and products for expressing proteins in cells

#71
20190330280
2019-10-31

Transcriptional regulatory fusion polypeptide

#72
20190276811
2019-09-12

High fidelity restriction endonucleases

#73
20190194755
2019-06-27

Analysis of methylation status and copy number

#74
20190169640
2019-06-06

DNA-binding proteins and uses thereof

#75
20190169240
2019-06-06

DNA-BINDING PROTEIN USING PPR MOTIF, AND USE THEREOF

#76
20190040397
2019-02-07

Method for producing DNA vectors from molecular bricks containing sequences of interest

#77
20180340189
2018-11-29

Using RNA-guided FokI nucleases (RFNs) to increase specificity for RNA-guided genome editing

#78
20180334689
2018-11-22

Artificial nucleases including engineered FokI cleavage half-domains

#79
20180273923
2018-09-27

TAL effector means useful for partial or full deletion of DNA tandem repeats

#80
20180237802
2018-08-23

Protein having nuclease activity, fusion proteins and uses thereof

#81
20180208957
2018-07-26

METHOD FOR IN VITRO TRANSCRIPTION USING AN IMMOBILIZED RESTRICTION ENZYME

#82
20180208921
2018-07-26

Increasing specificity for RNA-guided genome editing

#83
20180201955
2018-07-19

Targeted integration into the PPP1R12C locus

#84
20180163218
2018-06-14

Reconstruction of site specific nuclease binding sites

#85
20180163188
2018-06-14

Engineering of a minimal SaCas9 CRISPR/Cas system for gene editing and transcriptional regulation optimized by enhanced guide RNA

#86
20180148740
2018-05-31

Methods and compositions for treatment of a genetic condition

#87
20180148701
2018-05-31

High fidelity restriction endonucleases

#88
20180119175
2018-05-03

Methods and compositions for treatment of a genetic condition

#89
20180119121
2018-05-03

Modified cascade ribonucleoproteins and uses thereof

#90
20180112219
2018-04-26

Compositions comprising TALENs and methods of treating HIV

#91
20180051267
2018-02-22

TAL effector-mediated DNA modification

#92
20180051266
2018-02-22

TAL effector-mediated DNA modification

#93
20180030425
2018-02-01

Variants of CRISPR from and 1 (Cpf1)

#94
20180010152
2018-01-11

DNA-binding proteins and uses thereof

#95
20170362612
2017-12-21

Methods and products for expressing proteins in cells

#96
20170327848
2017-11-16

Artificial nucleases comprising engineered cleavage half-domains

#97
20170327805
2017-11-16

Using RNA-guided FokI nucleases (RFNs) to increase specificity for RNA-guided genome editing

#98
20170321214
2017-11-09

DEAD GUIDES FOR CRISPR TRANSCRIPTION FACTORS

#99
20170306335
2017-10-26

RNA-targeting system

#100
20170298450
2017-10-19

RECONSTRUCTION OF ANCESTRAL CELLS BY ENZYMATIC RECORDING

#101
20170283831
2017-10-05

Protected guide RNAS (PGRNAS)

#102
20170218400
2017-08-03

Methods and products for expressing proteins in cells

#103
20170198307
2017-07-13

METHODS FOR TARGETED MODIFICATION OF GENOMIC DNA

#104
20170152508
2017-06-01

Using truncated guide RNAs (tru-gRNAs) to increase specificity for RNA-guided genome editing

#105
20170088587
2017-03-30

ANTIVIRAL FUSION PROTEINS AND GENES

#106
20170043040
2017-02-16

Aptamer-mRNA conjugates for targeted protein or peptide expression and methods for their use

#107
20170029794
2017-02-02

TAL EFFECTOR MEANS USEFUL FOR PARTIAL OR FULL DELETION OF DNA TANDEM REPEATS

#108
20170022521
2017-01-26

Nanoparticle mediated delivery of sequence specific nucleases

#109
20170016030
2017-01-19

DNA-binding proteins and uses thereof

#110
20170015983
2017-01-19

Methods and products for expressing proteins in cells

#111
20170000904
2017-01-05

PHARMACOLOGICALLY INDUCED TRANSGENE ABLATION SYSTEM

#112
20160298138
2016-10-13

CRISPR-BASED GENOME MODIFICATION AND REGULATION

#113
20160298135
2016-10-13

CRISPR-based genome modification and regulation

#114
20160298134
2016-10-13

CRISPR-based genome modification and regulation

#115
20160298133
2016-10-13

CRISPR-BASED GENOME MODIFICATION AND REGULATION

#116
20160289699
2016-10-06

Targeted integration into the PPP1R12C locus

#117
20160289660
2016-10-06

High fidelity restriction endonucleases

#118
20160273002
2016-09-22

Rare-cutting endonucleases for efficient and specific targeting DNA sequences comprising highly repetitive motives

#119
20160265000
2016-09-15

Engineered cleavage half-domains for generating nuclease-mediated genomic modifications in a cell

#120
20160251649
2016-09-01

Methods and products for expressing proteins in cells

#121
20160186214
2016-06-30

Modified cascade ribonucleoproteins and uses thereof

#122
20160186152
2016-06-30

MODIFIED CASCADE RIBONUCLEOPROTEINS AND USES THEREOF

#123
20160186128
2016-06-30

Use of thermophilic nucleases for degrading nucleic acids

#124
20160153003
2016-06-02

Using RNA-guided FokI Nucleases (RFNs) to increase specificity for RNA-Guided Genome Editing

#125
20160138047
2016-05-19

IMPROVED POLYNUCLEOTIDE SEQUENCES ENCODING TALE REPEATS

#126
20160090607
2016-03-31

Methods and compositions for treatment of a genetic condition

#127
20160075744
2016-03-17

DNA-binding protein using PPR motif, and use thereof

#128
20160024524
2016-01-28

Increasing specificity for RNA-guided genome editing

#129
20160024523
2016-01-28

Using truncated guide RNAs (tru-gRNAs) to increase specificity for RNA-guided genome editing

#130
20160010076
2016-01-14

RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci

#131
20150275193
2015-10-01

Methods and products for expressing proteins in cells

#132
20150267223
2015-09-24

METHODS AND COMPOSITIONS FOR REGULATING HIV INFECTION

#133
20150267189
2015-09-24

Methods and products for expressing proteins in cells

#134
20150218253
2015-08-06

Methods and compositions for treatment of a beta thalessemia

#135
20150166998
2015-06-18

Aptamer-mRNA conjugates for targeted protein or peptide expression and methods for their use

#136
20150159176
2015-06-11

Engineered cleavage half-domains

#137
20150056705
2015-02-26

Methods and compositions for treatment of a genetic condition

#138
20140335618
2014-11-13

TAL effector-mediated DNA modification

#139
20140335592
2014-11-13

TAL EFFECTOR-MEDIATED DNA MODIFICATION

#140
20140298505
2014-10-02

Protein having nuclease activity, fusion proteins and uses thereof

#141
20140295557
2014-10-02

Using truncated guide RNAs (tru-gRNAs) to increase specificity for RNA-guided genome editing

#142
20140295556
2014-10-02

Using RNA-guided FokI nucleases (RFNs) to increase specificity for RNA-guided genome editing

#143
20140273126
2014-09-18

Method for increasing plant biomass using an exogenous gene encoding a thermophilic restriction enzyme

#144
20130196373
2013-08-01

Modified DNA-binding proteins and uses thereof

#145
20130137104
2013-05-30

Methods and compositions for modification of the HPRT locus

#146
20130022538
2013-01-24

Aptamer-mRNA conjugates for targeted protein or peptide expression and methods for their use

#147
20120331574
2012-12-27

USE OF MEGANUCLEASES FOR INDUCING HOMOLOGOUS RECOMBINATION EX VIVO AND IN TOTO IN VERTEBRATE SOMATIC TISSUES AND APPLICATION THEREOF

#148
20120322689
2012-12-20

USE OF MEGANUCLEASES FOR INDUCING HOMOLOGOUS RECOMBINATION EX VIVO AND IN TOTO IN VERTEBRATE SOMATIC TISSUES AND APPLICATION THEREOF

#149
20120317664
2012-12-13

Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof

#150
20120304321
2012-11-29

USE OF MEGANUCLEASES FOR INDUCING HOMOLOGOUS RECOMBINATION EX VIVO AND IN TOTO IN VERTEBRATE SOMATIC TISSUES AND APPLICATION THEREOF

#151
20120288943
2012-11-15

USE OF MEGANUCLEASES FOR INDUCING HOMOLOGOUS RECOMBINATION EX VIVO AND IN TOTO IN VERTEBRATE SOMATIC TISSUES AND APPLICATION THEREOF

#152
20120288942
2012-11-15

USE OF MEGANUCLEASES FOR INDUCING HOMOLOGOUS RECOMBINATION EX VIVO AND IN TOTO IN VERTEBRATE SOMATIC TISSUES AND APPLICATION THEREOF

#153
20120288941
2012-11-15

Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof

#154
20120252072
2012-10-04

Restriction/modification polypeptides, polynucleotides, and methods

#155
20120214228
2012-08-23

TAL effector-mediated DNA modification

#156
20120178169
2012-07-12

Tal effector-mediated DNA modification

#157
20120178131
2012-07-12

TAL effector-mediated DNA modification

#158
20120159659
2012-06-21

CUSTOM-MADE MEGANUCLEASE AND USE THEREOF

#159
20120142062
2012-06-07

Engineered cleavage half-domains

#160
20120142055
2012-06-07

Targeted integration into the PPP1R12C locus

#161
20120058102
2012-03-08

Pharmacologically induced transgene ablation system

#162
20110301073
2011-12-08

DNA-binding proteins and uses thereof

#163
20110287513
2011-11-24

Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof

#164
20110201055
2011-08-18

Engineered cleavage half-domains

#165
20110151539
2011-06-23

USE OF MEGANUCLEASES FOR INDUCING HOMOLOGOUS RECOMBINATION EX VIVO AND IN TOTO IN VERTEBRATE SOMATIC TISSUES AND APPLICATION THEREOF

#166
20110151450
2011-06-23

High fidelity restriction endonucleases

#167
20110145940
2011-06-16

TAL effector-mediated DNA modification

#168
20110033384
2011-02-10

CHIMERIC POLYPEPTIDES AND THEIR USE

#169
20110030076
2011-02-03

Methods and compositions for targeted cleavage and recombination

#170
20100311168
2010-12-09

Nanoparticle mediated delivery of sequence specific nucleases

#171
20100144012
2010-06-10

Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof

#172
20080299580
2008-12-04

Targeted integration into the PPP1R12C locus

#173
20060292629
2006-12-28

Chimeric polypeptides and their use

#174
20060206949
2006-09-14

Custom-made meganuclease and use thereof

#175
20060153826
2006-07-13

Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof

#176
20050064474
2005-03-24

Methods and compositions for targeted cleavage and recombination

#177
17463581
2022-03-08

Nucleic acid-guided nickases